埃达拉沃恩的安全评估:基于FAERS数据库的现实世界不良事件分析
Ziyue Wang1, Bowen Lu2, Hao Yang3
1College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan City, Shandong Province, China.
PloS one
|October 23, 2025
概括
以达拉为神经保护药物,使用现实世界的数据分析了不良事件 (AE). 该研究确定了包括死亡,疾病进展和药物无效性在内的重大副作用,突出了被忽视的安全问题.
科学领域:
- 药物监督 药物监督 药物监督
- 神经保护是一种神经保护.
- 现实世界的证据.
背景情况:
- 埃达拉是一种神经保护剂,具有不完全特征的不良事件 (AE).
- 现实世界的数据分析对于理解药物安全性概况至关重要.
- 美国食品和药物管理局的不良事件报告系统 (FAERS) 为药物监督提供了宝贵的资源.
研究的目的:
- 调查与埃达拉使用相关的不良事件的特征.
- 分析来自FAERS数据库的现实数据,以确定潜在的安全信号.
- 为了检测与edaravone相关的统计学上显著的AE信号.
主要方法:
- 来自FAERS (2017年第二季度 - 2024年第二季度) 的埃达拉相关不良事件报告的回顾性分析.
- 不成比例分析方法的应用:报告概率比率 (ROR),比例报告比率 (PRR) 和贝叶斯信心传播神经网络 (BCPNN).
- 标识显著的首选术语 (PTs) 和系统器官类 (SOCs),表明AE信号.
主要成果:
- 分析了2,931份关于埃达拉作为首要疑似药物的不良事件报告.
- 在PT层面确定的与药物相关的显著副作用包括死亡 (ROR=8.64),疾病进展 (ROR=28.26) 和药物无效 (ROR=2.16).
- 观察到罕见但强烈的AE信号:导管部位的血栓形成,胃,静脉缩.
结论:
- 埃达拉与几个被忽视的不良反应有关.
- 需要进一步的流行病学研究来全面评估edaravone的风险益处概况.
- 现实世界的数据分析揭示了像edaravone这样的神经保护剂的关键安全见解.
相关概念视频
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Therapeutic Drug Monitoring: Affecting Factors
200
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
200
Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
404
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
404
Cardiopulmonary Resuscitation III: AED Use
526
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
526
Hazard Ratio
559
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
559


